11 Jun CASE: Patient CB has a history of strokes
CASE: Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
• Glipizide 10 mg po daily
• HCTZ 25 mg daily
• Atenolol 25 mg po daily
• Hydralazine 25 mg qid
• Simvastatin 80 mg daily
• Verapamil 180 mg CD daily
•
3.Select one of the following factors: genetics, gender, ethnicity, age, or behavior factors.
Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
4. Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
•
5. Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes.
Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
Assignment: Pharmacotherapy for Cardiovascular Disorders
By Day 7 of Week 2
Write a 2- to 3-page paper that addresses the following:
• 1.Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
CASE: Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
• Glipizide 10 mg po daily
• HCTZ 25 mg daily
• Atenolol 25 mg po daily
• Hydralazine 25 mg qid
• Simvastatin 80 mg daily
• Verapamil 180 mg CD daily
•
• 2. Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
